Pelvic Health

FEMSelect Closes Series B to Advance Pelvic Organ Prolapse Technology

Non-Invasive Stress Urinary Incontinence Device Elitone Now Available Through NHS in the UK

Medtech Startup UVISA Secures $600K and Approval for Vaginal Infection Light Therapy Clinical Trial

Intravaginal Electrical Stimulation Meets Menstrual Care: How Belgian Startup Mirapulse Tackles Severe Period Pain

Danish Incontinence Device Company Magcath Secures €535K in New Funding for European Launch

Digital Health Company Amara Therapeutics Launches US Clinical Trial for Overactive Bladder Treatment Following €1.8M Funding Round

Women’s Healthtech Company Fizimed Raises €4M for International Expansion

Uresta Launches U.S. Expansion with $3M Funding to Address Bladder Leaks

Wisp and Origin Partner to Offer Pelvic Physical Therapy to Telehealth Patients

Pelva Health Raises $500K Pre-Seed Round to Develop Solutions for Intimacy Pain

Materna Medical Reveals Early Findings from Study on Vaginal Muscle Tightness and Painful Intercourse

Kaia Health Partners with Vira Health to Deliver Digital Pelvic Floor Therapy and Menopause Support

Study Validates Pelvital’s Mechanotherapy Treatment for Stress Urinary Incontinence

Hinge Health Digital Program Shows 53% Reduction in Chronic Pelvic Pain in New Study

Mayo Clinic Invests in Axena Health, Adding Educational Content to Pelvic Care Platform

US Pelvic Health Company Elitone Launches in UK with Non-Invasive Pelvic Floor Treatment Device

FemPulse Receives FDA Clearance to Begin Pivotal Trial for Women’s Overactive Bladder Device

ConTIPI Medical Launches ProVate Device for Pelvic Organ Prolapse in the U.S.

Evvy Expands into Treatment with New Prescription Product Line for Vaginal Health

Caldera Medical Acquires UVision360 to Expand Hysteroscopy Portfolio

New Study Shows Promise for EnPlace Minimally Invasive Pelvic Organ Prolapse Treatment

Peer-Reviewed Study Confirms Accuracy of Evvy’s Vaginal Microbiome Test

Hologic to Acquire Gynesonics for $350 Million; Expanding Fibroid Treatment Options

Axena Health’s Leva System Included in NIH-Funded Clinical Trial for Postpartum Urinary Incontinence Treatment